WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 555186

CAS#: 2102196-57-4

Description: MDK6574, also known as FAA1 agonist-1, is a FAA1 agonist. MDK6574 has CAS#2102196-57-4. The last 4 digit of its CAS# is used for naming for the convenience of scientific communication.

Price and Availability

Size Price Shipping out time Quantity
200mg USD 950 2 Weeks
500mg USD 1950 2 Weeks
1g USD 2650 2 Weeks
2g USD 4250 2 Weeks
5g USD 6950 2 Weeks
Inquire bulk and customized quantity

Pricing updated 2021-01-20. Prices are subject to change without notice.

MDK6574, purity > 98%, is in stock. Current shipping out time is about 2 weeks after order is received. CoA, QC data and MSDS documents are available in one week after order is received.

Chemical Structure


Theoretical Analysis

MedKoo Cat#: 555186
Name: MDK6574
CAS#: 2102196-57-4
Chemical Formula: C21H17ClO5S
Exact Mass: 416.0485
Molecular Weight: 416.872
Elemental Analysis: C, 60.51; H, 4.11; Cl, 8.50; O, 19.19; S, 7.69

Synonym: FAA1 agonist-1; FAA1 agonist 1; FAA1 agonist1; MDK6574; MDK-6574; MDK 6574.

IUPAC/Chemical Name: 2-((4-((2'-chloro-[1,1'-biphenyl]-3-yl)methoxy)phenyl)sulfonyl)acetic acid


InChi Code: InChI=1S/C21H17ClO5S/c22-20-7-2-1-6-19(20)16-5-3-4-15(12-16)13-27-17-8-10-18(11-9-17)28(25,26)14-21(23)24/h1-12H,13-14H2,(H,23,24)

SMILES Code: ClC1=CC=CC=C1C2=CC(COC3=CC=C(S(CC(O)=O)(=O)=O)C=C3)=CC=C2

Technical Data

Solid powder

>98% (or refer to the Certificate of Analysis)

Shipping Condition:
Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition:
Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Soluble in DMSO

Shelf Life:
>2 years if stored properly

Drug Formulation:
This drug may be formulated in DMSO

Stock Solution Storage:
0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code:


1. Li Z, et al. Discovery of phenylsulfonyl acetic acid derivatives with improved efficacy and safety as potent free fatty acid receptor 1 agonists for the treatment of type 2 diabetes. Eur J Med Chem. 2017 Sep 29;138:458-479.